DWM
GSK icon

Destination Wealth Management’s GSK GSK Stock Holding History

Destination Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-146
Closed -$7K – 276
2019
Q2 		$7K Sell
146
-415
-74% -$20.8K ﹤0.01% 459
2019
Q1 		$29K Buy
561
+81
+17% +$4.05K ﹤0.01% 349
2018
Q4 		$23K Hold
480
– – ﹤0.01% 342
2018
Q3 		$24K Hold
480
– – ﹤0.01% 379
2018
Q2 		$24K Buy
480
+426
+789% +$21.5K ﹤0.01% 331
2018
Q1 		$3K Buy
+54
New +$2.52K ﹤0.01% 481

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Destination Wealth Management's GSK Position: Q3 2019 in Review

Destination Wealth Management sold out of GSK (GSK) in Q3 2019, closing a stake of 146 shares — an estimated $7K sold.

Destination Wealth Management first reported a position in GSK in Q1 2018 and held it in 6 quarters. The position peaked at $29K in Q1 2019. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • Destination Wealth Management reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
  • Destination Wealth Management sold 146 GSK shares in Q3 2019, an estimated $7K.
  • Destination Wealth Management first reported a position in GSK in Q1 2018 and held it in 6 quarters.
  • Destination Wealth Management's GSK position peaked at $29K in Q1 2019.
  • 805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Destination Wealth Management's 13F filing for Q3 2019, filed 13 Nov 2019.